loading
전일 마감가:
$5.59
열려 있는:
$5.42
하루 거래량:
51,118
Relative Volume:
0.67
시가총액:
$147.63M
수익:
$21.25M
순이익/손실:
$-16.05M
주가수익비율:
-8.5902
EPS:
-0.61
순현금흐름:
$-17.14M
1주 성능:
-19.38%
1개월 성능:
-22.14%
6개월 성능:
+13.42%
1년 성능:
-51.97%
1일 변동 폭
Value
$5.0987
$5.61
1주일 범위
Value
$5.0987
$6.48
52주 변동 폭
Value
$3.96
$11.11

Fennec Pharmaceuticals Inc Stock (FENC) Company Profile

Name
명칭
Fennec Pharmaceuticals Inc
Name
전화
(919) 636-4530
Name
주소
PO BOX 13628, RESEARCH TRIANGLE PARK, NC
Name
직원
32
Name
트위터
@FennecPharma
Name
다음 수익 날짜
2025-03-10
Name
최신 SEC 제출 서류
Name
FENC's Discussions on Twitter

FENC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
FENC
Fennec Pharmaceuticals Inc
5.225 147.63M 21.25M -16.05M -17.14M -0.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
481.52 125.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
587.94 65.79B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
559.38 35.18B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
244.81 32.67B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
240.59 26.46B 3.81B -644.79M -669.77M -6.24

Fennec Pharmaceuticals Inc Stock (FENC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-11-22 업그레이드 Cantor Fitzgerald Neutral → Overweight
2022-09-07 개시 CapitalOne Overweight
2022-08-08 재개 Craig Hallum Buy
2020-06-05 개시 Cantor Fitzgerald Overweight
2018-10-11 개시 Goldman Buy

Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스

pulisher
Apr 02, 2025

Vitro Diagnostics (OTCMKTS:VODG) & Fennec Pharmaceuticals (NASDAQ:FENC) Head to Head Survey - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below 50 Day Moving Average – Should You Sell? - Defense World

Apr 01, 2025
pulisher
Apr 01, 2025

Fennec Pharmaceuticals Inc (NASDAQ:FENC) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World

Apr 01, 2025
pulisher
Mar 27, 2025

(FENC) Investment Analysis and Advice - news.stocktradersdaily.com

Mar 27, 2025
pulisher
Mar 26, 2025

Fennec Pharmaceuticals Achieves Strong Growth and Expands Market Reach in 2024 - TipRanks

Mar 26, 2025
pulisher
Mar 24, 2025

Long Term Trading Analysis for (FRX) (FRX:CA) - news.stocktradersdaily.com

Mar 24, 2025
pulisher
Mar 19, 2025

(FRX) Stock Market Analysis (FRX:CA) - news.stocktradersdaily.com

Mar 19, 2025
pulisher
Mar 16, 2025

(FENC) Technical Data - news.stocktradersdaily.com

Mar 16, 2025
pulisher
Mar 15, 2025

(FRX) Equity Market Report (FRX:CA) - news.stocktradersdaily.com

Mar 15, 2025
pulisher
Mar 14, 2025

Q1 EPS Forecast for Fennec Pharmaceuticals Raised by Analyst - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

HC Wainwright Has Positive Forecast for TSE:FRX Q1 Earnings - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

Wedbush Research Analysts Boost Earnings Estimates for FENC - Defense World

Mar 14, 2025
pulisher
Mar 14, 2025

What is HC Wainwright’s Forecast for FENC Q1 Earnings? - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

US$12.60: That's What Analysts Think Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Is Worth After Its Latest Results - Simply Wall St

Mar 13, 2025
pulisher
Mar 13, 2025

Wedbush Boosts Earnings Estimates for Fennec Pharmaceuticals - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Fennec Pharmaceuticals (FENC) Projected to Post Quarterly Earnings on Thursday - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Fennec Pharmaceuticals: Strong Growth Potential with PEDMARK’s Market Expansion and Strategic Focus - TipRanks

Mar 12, 2025
pulisher
Mar 12, 2025

Fennec Pharmaceuticals (NASDAQ:FENC) Receives Buy Rating from HC Wainwright - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Fennec Pharmaceuticals Reports Strong Growth Amid Challenges - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Fennec Pharmaceuticals: Strategic Market Expansion and Financial Performance Justify Buy Rating - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

(FRX) Technical Data (FRX:CA) - news.stocktradersdaily.com

Mar 11, 2025
pulisher
Mar 11, 2025

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 11, 2025
pulisher
Mar 11, 2025

Rhumbline Advisers Grows Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Fennec Pharmaceuticals (NASDAQ:FENC) Receives “Outperform” Rating from Wedbush - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Fennec Pharmaceuticals Reports Strong 2024 Sales Growth - TipRanks

Mar 11, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results - TradingView

Mar 10, 2025
pulisher
Mar 10, 2025

Earnings call transcript: Fennec Pharmaceuticals Q4 2024 earnings beat forecasts By Investing.com - Investing.com South Africa

Mar 10, 2025
pulisher
Mar 10, 2025

Wedbush Reviews Fennec Pharmaceuticals' Q4 -March 10, 2025 at 12:48 pm EDT - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Q4 revenue beats, stock tumbles 16% By Investing.com - Investing.com Canada

Mar 10, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Q4 revenue beats, stock tumbles 16% - Investing.com

Mar 10, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 10, 2025
pulisher
Mar 10, 2025

Earnings call transcript: Fennec Pharmaceuticals Q4 2024 earnings beat forecasts - Investing.com

Mar 10, 2025
pulisher
Mar 10, 2025

Investing in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago would have delivered you a 38% gain - Yahoo Finance

Mar 10, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Reports Strong 2024 Financials and Expands Global Reach - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 10, 2025
pulisher
Mar 10, 2025

FENNEC PHARMACEUTICALS Earnings Results: $FENC Reports Quarterly Earnings - Nasdaq

Mar 10, 2025
pulisher
Mar 10, 2025

Earnings Flash (FRX.TO) Fennec Pharmaceuticals Posts Q4 Revenue US$7.925 Million - Marketscreener.com

Mar 10, 2025
pulisher
Mar 10, 2025

Fennec Pharmaceuticals Inc Q4 Loss Decreases, Beats Estimates - Nasdaq

Mar 10, 2025
pulisher
Mar 10, 2025

Earnings Scheduled For March 10, 2025 - Benzinga

Mar 10, 2025
pulisher
Mar 08, 2025

Fennec Pharmaceuticals (FENC) Projected to Post Quarterly Earnings on Monday - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Fennec Pharmaceuticals director Raykov sells $67,900 in stock By Investing.com - Investing.com Canada

Mar 07, 2025
pulisher
Mar 06, 2025

Fennec Pharmaceuticals director Raykov sells $67,900 in stock - Investing.com

Mar 06, 2025
pulisher
Mar 06, 2025

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025 - The Manila Times

Mar 06, 2025
pulisher
Mar 06, 2025

Trading (FENC) With Integrated Risk Controls - Stock Traders Daily

Mar 06, 2025
pulisher
Mar 02, 2025

(FRX) Investment Analysis and Advice (FRX:CA) - Stock Traders Daily

Mar 02, 2025
pulisher
Feb 24, 2025

Trading (FRX) With Integrated Risk Controls (FRX:CA) - Stock Traders Daily

Feb 24, 2025
pulisher
Feb 18, 2025

Chris Anigeron Rallis Sells 1,186 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) Stock - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

(FRX) Proactive Strategies (FRX:CA) - Stock Traders Daily

Feb 17, 2025
pulisher
Feb 16, 2025

Fennec Pharmaceuticals (TSE:FRX) Stock Passes Above 50-Day Moving AverageHere's Why - MarketBeat

Feb 16, 2025

Fennec Pharmaceuticals Inc (FENC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$66.10
price down icon 2.65%
$73.33
price down icon 0.15%
$31.60
price up icon 0.06%
$18.91
price down icon 11.53%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 7.93%
자본화:     |  볼륨(24시간):